BioNTech SE (BNTX) Depreciation & Amortization (CF) (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Depreciation & Amortization (CF) data on file, last reported at $57.7 million in Q2 2025.

• In Q2 2025, Depreciation & Amortization (CF) rose 7.43% year-over-year to $57.7 million; the TTM figure through Dec 2025 stood at $102.8 million (down 67.98% YoY), while the FY2024 annual figure was $318.4 million, up 61.38% from the prior year.
• Depreciation & Amortization (CF) improved to $57.7 million in Q2 2025, from $45.0 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $176.7 million in Q4 2024 and bottomed at $15.68 in Q1 2021.
• A 5-year average of $47.7 million and a median of $38.5 million in 2022 frame the typical range for Depreciation & Amortization (CF).
• The widest YoY moves for Depreciation & Amortization (CF): up 199570464.14% in 2021, down 100.0% in 2021.
• Year by year, Depreciation & Amortization (CF) stood at $29.7 million in 2021, then fell by 0.52% to $29.6 million in 2022, then jumped by 186.56% to $84.8 million in 2023, then jumped by 108.47% to $176.7 million in 2024, then sank by 67.34% to $57.7 million in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $57.7 million (Q2 2025), $45.0 million (Q1 2025), and $176.7 million (Q4 2024), per Business Quant data.

Peer Comparison